Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006965
Filing Date
2019-05-14
Accepted
2019-05-13 18:46:23
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 429738
2 ex31-1.htm EX-31.1 11658
3 ex31-2.htm EX-31.2 11679
4 ex32-1.htm EX-32.1 6604
5 ex32-2.htm EX-32.2 6564
  Complete submission text file 0001493152-19-006965.txt   2943690

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bblg-20190331.xml EX-101.INS 479705
7 XBRL SCHEMA FILE bblg-20190331.xsd EX-101.SCH 52199
8 XBRL CALCULATION FILE bblg-20190331_cal.xml EX-101.CAL 32996
9 XBRL DEFINITION FILE bblg-20190331_def.xml EX-101.DEF 160277
10 XBRL LABEL FILE bblg-20190331_lab.xml EX-101.LAB 329280
11 XBRL PRESENTATION FILE bblg-20190331_pre.xml EX-101.PRE 226431
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

IRS No.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53078 | Film No.: 19820010
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies